Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.73 |
| ▸ | CTSB | P07858 | 3/20 | 0.73 |
| ▸ | CTSS | P25774 | 2/20 | 0.73 |
| ▸ | CTSK | P43235 | 1/20 | 0.73 |
| ▸ | TACR1 | P25103 | 2/20 | 0.67 |
| ▸ | MME | P08473 | 1/20 | 0.63 |
| ▸ | ECE1 | P42892 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9557048 | 1.00 | CTSL (0.73) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL31207208 | 0.97 | CTSL (0.70) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL10521480 | 0.97 | CTSL (0.70) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7350864 | 0.94 | CTSL (0.69) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7325767 | 0.94 | CTSL (0.69) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7350862 | 0.93 | CTSL (0.64) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7325764 | 0.93 | CTSL (0.64) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7360694 | 0.92 | CTSS (0.63) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL11022927 | 0.91 | CTSL (0.61) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL8335400 | 0.91 | CTSL (0.71) | CTSLCTSBCTSSCTSKTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008808-A1 | Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component | UNIV GUANGZHOU MEDICAL (CN) | 2026-01-08 | — | — | US | disclosed |
| EP-4574834-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE WITH UNPROTECTED AMINO ACID AS AMINE COMPONENT | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024139061-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE WITH UNPROTECTED AMINO ACID AS AMINE COMPONENT | 广州医科大学 | 2024-07-04 | — | — | WO | disclosed |
| CN-116675727-A | Method for synthesizing amide and/or polypeptide by taking unprotected amino acid as ammonia component | 广州医科大学 | 2023-09-01 | — | — | CN | disclosed |
| US-5925633-A | ADMINISTERING AS ANTIMETASTASIS AGENT | SYNPHAR LABORATIES, INC. (CA) | 1999-07-20 | — | — | US | disclosed |
| WO-1997032580-A1 | 3-SUBSTITUTED-4-OXA-1-AZABICYCLO[3,2,0]HEPTAN-7-ONE AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (US) | 1997-09-12 | — | — | WO | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0272671-B1 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD (CH) | 1994-03-16 | — | — | EP | disclosed |
| US-5223486-A | Modified oligopeptide containing a diazomethyl ketone group or methylsulfonium group | UNIVERSITY RESEARCH CORPORATION (US) | 1993-06-29 | — | — | US | disclosed |
| US-4188319-A | ANTIBIOTICS | ABBOTT LABORATORIES (US) | 1980-02-12 | — | — | US | disclosed |
| US-4174312-A | ACYLATION, HYDROLYSIS, SALT FORMATION, CATALYTIC HYDROGENATION | ABBOTT LABORATORIES (US) | 1979-11-13 | — | — | US | disclosed |
| US-4173564-A | 4-N-acylfortimicin B derivatives and the chemical conversion of fortimicin B to fortimicin A | ABBOTT LABORATORIES (US) | 1979-11-06 | — | — | US | disclosed |
| US-4155902-A | ACYLATION, HYDROGENOLYSIS | ABBOTT LABORATORIES (US) | 1979-05-22 | — | — | US | disclosed |
| US-4091032-A | ANTIMICROBIAL AGENTS | ABBOTT LABORATORIES (US) | 1978-05-23 | — | — | US | disclosed |
| US-RE29369-E | AMIDE PRODUCT, SALTS OF HYDROXY-SUBSTITUTED PYRIDINE COMPOUNDS | KYOWA HAKKO KOGYO CO., LTD. (JA) | 1977-08-23 | — | — | US | disclosed |
| US-4043992-A | Method for preparing acylated products | KYOWA HAKKO KOGYO CO., LTD. (JA) | 1977-08-23 | — | — | US | disclosed |
| US-3984417-A | Method of producing active amino acid esters | AJINOMOTO CO., INC. (JA) | 1976-10-05 | — | — | US | disclosed |
| US-3963728-A | ACYLATION OF NITROGEN CONTAINING COMPOUNDS USING ESTERS | KYOWA HAKKO KOGYO CO., LTD. (JA) | 1976-06-15 | — | — | US | disclosed |
| US-3933783-A | Formation of peptide bonds in the presence of isonitriles | AJINOMOTO CO., INC. (JA) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008808-A1 | Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component | ANPEP, PTMS, GCG | CTSL 67/4885CTSB 1923/4885CTSS 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.